User profiles for Naoyuki Miyashita

Naoyuki Miyashita

KINDAI University
Verified email at waka.kindai.ac.jp
Cited by 1198

The JRS guidelines for the management of community-acquired pneumonia in adults: an update and new recommendations

N Miyashita, T Matsushima, M Oka - Internal medicine, 2006 - jstage.jst.go.jp
Community-acquired pneumonia (CAP) continues to be a major medical problem. Since CAP
is a potentially fatal disease, early appropriate antibiotic treatment is vital. Epidemiologic …

A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial …

…, EC Gabazza, Y Takei, N Miyashita… - Clinical infectious …, 2013 - academic.oup.com
Background. Optimal empiric therapy for hospitalized patients with healthcare-associated
pneumonia (HCAP) is uncertain. Methods. We prospectively applied a therapeutic algorithm, …

[HTML][HTML] Molecular dynamics simulations of biological membranes and membrane proteins using enhanced conformational sampling algorithms

T Mori, N Miyashita, W Im, M Feig, Y Sugita - Biochimica et Biophysica Acta …, 2016 - Elsevier
This paper reviews various enhanced conformational sampling methods and explicit/implicit
solvent/membrane models, as well as their recent applications to the exploration of the …

Nationwide surveillance of macrolide-resistant Mycoplasma pneumoniae infection in pediatric patients

Y Kawai, N Miyashita, M Kubo, H Akaike… - Antimicrobial agents …, 2013 - Am Soc Microbiol
We conducted nationwide surveillance to investigate regional differences in macrolide-resistant
(MR) Mycoplasma pneumoniae strains in Japan. The prevalence of MR M. pneumoniae …

Structural role of countertransport revealed in Ca2+ pump crystal structure in the absence of Ca2+

K Obara, N Miyashita, C Xu… - Proceedings of the …, 2005 - National Acad Sciences
Ca 2+ -ATPase of sarcoplasmic reticulum is an ATP-powered Ca 2+ pump but also a H +
pump in the opposite direction with no demonstrated functional role. Here, we report a 2.4-Ć-…

Therapeutic efficacy of macrolides, minocycline, and tosufloxacin against macrolide-resistant Mycoplasma pneumoniae pneumonia in pediatric patients

Y Kawai, N Miyashita, M Kubo, H Akaike… - Antimicrobial agents …, 2013 - Am Soc Microbiol
The importance of macrolide-resistant (MR) Mycoplasma pneumoniae has become much
more apparent in the past decade. We investigated differences in the therapeutic efficacies of …

Clinical features of severe Mycoplasma pneumoniae pneumonia in adults admitted to an intensive care unit

N Miyashita, Y Obase, K Ouchi… - Journal of medical …, 2007 - microbiologyresearch.org
Community-acquired pneumonia (CAP) due to Mycoplasma pneumoniae is usually mild,
but some cases develop a severe life-threatening pneumonia. To investigate the clinical …

Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level

N Inamura, N Miyashita, S Hasegawa, A Kato… - Journal of Infection and …, 2014 - Elsevier
It has been suggested that cytokines are associated with refractory Mycoplasma pneumoniae
pneumonia, and steroid administration is reported to be effective in this situation. In order …

Plaque Formation by and Plaque Cloning ofChlamydia trachomatis Biovar Trachoma

A Matsumoto, H Izutsu, N Miyashita… - Journal of clinical …, 1998 - Am Soc Microbiol
A new technique for the induction of plaque formation byChlamydia trachomatis biovar
trachoma applicable to the titration of infectivity and cloning of biovar trachoma was established. …

Atypical pneumonia: Pathophysiology, diagnosis, and treatment

N Miyashita - Respiratory investigation, 2022 - Elsevier
Atypical pneumonia is caused by atypical pathogens that are not detectable with Gram stain
and cannot be cultured using standard methods. The most common causative organisms of …